Omnicell (OMCL) Other Operating Expenses (2010 - 2022)

Omnicell's (OMCL) quarterly Other Operating Expenses came in at -$3.5 million in Q1 2022, down 75.0% year-on-year from -$14.0 million in Q1 2021, and down 75.0% on a QoQ basis from -$2.0 million in Q1 2021.

Omnicell (OMCL) Other Operating Expenses (2010 - 2022) Analysis & Trends

Omnicell (OMCL) has 4 years of Other Operating Expenses data on file, last reported at -$3.5 million in Q1 2022.

  • On a quarterly basis, Other Operating Expenses fell 75.0% year-over-year to -$3.5 million in Q1 2022; TTM through Dec 2022 was -$3.5 million, a 75.0% decrease from a year earlier, with the FY2015 full-year figure at -$3.4 million, changed N/A from the prior year.
  • Other Operating Expenses for Q1 2022 stood at -$3.5 million, down from -$2.0 million in the prior quarter.
  • Over the last five years, Other Operating Expenses for OMCL reached as high as -$2.0 million in Q1 2021 and fell as low as -$3.5 million in Q1 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Veeva Systems 29.34 Bn 22.03 Bn 662.02 Mn
2 BrightSpring Health Services 13.49 Bn 12.59 Bn 482.22 Mn
3 Healthequity 7.96 Bn 7.70 Bn 256.31 Mn
4 10x Genomics 6.17 Bn 5.63 Bn 106.18 Mn
5 Hinge Health 6.02 Bn 5.70 Bn 154.23 Mn
6 MiniMed 4.19 Bn 3.89 Bn 480.00 Mn
7 Waystar Holding 4.14 Bn 4.07 Bn 216.84 Mn
8 Doximity 3.82 Bn 3.08 Bn 125.97 Mn
9 Privia Health 3.10 Bn 2.73 Bn -
10 Omnicell 1.81 Bn 1.57 Bn 140.36 Mn

Historic Data

Download Data
DateValue
Mar 31, 2022 -3.50 Mn
Mar 31, 2021 -2.00 Mn
Jun 30, 2015 -3.44 Mn
Sep 30, 2010 -43,000.00